PTIX - protagenic.com Net earnings per share (EPS TTM)

PTIX (Protagenic Therapeutics) - company brandmark

Protagenic Therapeutics (PTIX) is protected by patents for PT00114 peptides and a powerful lobby, despite stringent FDA oversight. The change in rolling net income per share provided by the GURU.Markets system demonstrates a trend where -7.18 forms the current metric value. The business model relies on future superprofits from the serial production of drugs, although risks remain regarding potential test failures and liquidity shortages.

PTIX (Protagenic) Net earnings per share for the trailing year history from 07/04/2022 to 01/10/2026

Financial and market metric breakdowns for Protagenic Therapeutics Inc. (PTIX)

- share price and expert price forecast:
Stock Quotes Protagenic|PTIX - Analyst Forecast Prices
- market capitalization statistics:
Market Capitalization Protagenic Therapeutics, Inc.|PTIX - Enterprise Value
- business book valuation details:
Book Value per Share Protagenic Therapeutics|PTIX - Book Value of Business|Market Capitalization to Book Value Ratio protagenic.com|PTIX - Company Assets
- debt level and financial liquidity data:
Debt to Equity Protagenic Therapeutics|PTIX - Long-Term Debt to Capital Ratio|Short-Term Debt to Capital Protagenic|PTIX - Company Total Debt Obligations|Debts to Book Capitalization Protagenic Therapeutics, Inc.|PTIX - Company Long-Term Liabilities|Company Current Liabilities Protagenic Therapeutics|Quick Liquidity Indicator protagenic.com
- net income and valuation multiples indicators:
PTIX - Profit After Payment of Taxes|Projected Future Earnings Protagenic Therapeutics|PTIX - Company Value to Net Income|Forward P/E Multiple Protagenic|PTIX - Price to Earnings Adjusted for Growth Rate|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Protagenic Therapeutics, Inc.|PTIX - Income before deduction of interest, taxes and amortization|Net earnings per share (EPS TTM) Protagenic Therapeutics|PTIX - Net earnings per share (EPS TTM)|Year-over-year earnings per share growth for the last twelve months protagenic.com|PTIX - Earnings per share trend in current year|Earnings growth forecast for next year Protagenic Therapeutics
- sales volume and revenue indicators:
PTIX - Company Total Revenue|Company Future Sales Volume Protagenic|PTIX - P/S Multiple|Forward Price-to-Revenue Multiple Protagenic Therapeutics, Inc.
Fundamental company analysis:protagenic.com (PTIX)
Mass-produced product of Protagenic Therapeutics Inc.

The fundamental value of Protagenic Therapeutics (PTIX) is determined by its ability to generate real earnings per share. By analyzing the TTM earnings per share trend, an investor sees the net financial result for the year, stripped of the influence of the total issuance volume. This indicator filters out market noise, capturing business expansion phases. For Protagenic Therapeutics (PTIX), the automation of neuropeptide synthesis must translate into growth for this metric. A positive trend would confirm the effectiveness of its bioinformatics platforms.

Competitor analysis

BIIB: Net earnings per share for the last 12 months|neurocrine.com - Earnings per share for the last four quarters|RGC: Net earnings per share (EPS TTM)|Axsome (AXSM) - Net earnings per share (EPS TTM)|ACAD (ACADIA Pharmaceuticals Inc) - Net earnings per share (EPS TTM)|XENE - Net earnings per share for the trailing year|Net earnings per share (EPS TTM) VKTX|SUPN - Net earnings per one share for the last twelve months|Earnings per share for the last twelve months Catalyst Pharmaceuticals, Inc. CPRX|DNLI: Earnings per share for the last 12 months|Harmony Pharma - Net earnings per share (EPS TTM)|Net earnings per share for the last four quarters Biohaven Corp BHVN|AMLX: Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months trevitherapeutics.com|Net earnings per share for the last 12 months PRAX|AVXL: Earnings per share for the trailing year|Net earnings per share for the last 12 months CBLL (CeriBell Corp)|Earnings per share for the last four quarters PRTA|Net earnings per share (EPS TTM) ALEC (Alector)|Earnings per share for the trailing year ANNX|Omeros Corp. - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Neurogene Inc|AC Immune Corp (ACIU) - Earnings per share for the last twelve months|Voyager Corp - Earnings per share for the trailing year|NMRA (Neumora Therapeutics) - Net earnings per share (EPS TTM)|Net earnings per share (EPS TTM) scilexholding.com|Earnings per share for the last twelve months Tevogen Bio (TVGN)|ACOG: Earnings per one share for the last 12 months|Net earnings per share (EPS TTM) CGTX (Cognition Therapeutics)|Inhibikase Pharma (IKT) - Net earnings per one share for the last twelve months|SAVA: Net earnings per share for the last 12 months|ASRT - Net earnings per share (EPS TTM)|COYA (coyatherapeutics.com) - Net earnings per share for the last 12 months|VTGN: Earnings per share for the last four quarters|OVID (Ovid Therapeutics Inc) - Net earnings per share (EPS TTM)|Acumen Pharmaceuticals, Inc (ABOS) - Net earnings per share for the last four quarters|Net earnings per share (EPS TTM) CRVO|Net earnings per share for the last 12 months alteritytherapeutics.com ATHE|Earnings per share for the last twelve months Clene CLNN|Net earnings per share for the last four quarters PepGen Inc (PEPG)|JUNS - Earnings per share for the last twelve months|Earnings per one share for the last 12 months RLMD|ANVS (Annovis Bio, Inc.) - Net earnings per share for the last 12 months|GRCE: Earnings per share for the last four quarters|AIFF (Firefly Neuroscience) - Net earnings per share (EPS TTM)|ANEW Medical, Inc. (KLTO) - Net earnings per share for the last four quarters|Net earnings per share for the last 12 months NRSN (NeuroSense Therapeutics)|Reviva Pharmaceuticals, Inc. - Earnings per share for the last 12 months|Earnings per share for the last twelve months MetaVia MTVA|NRXS: Earnings per share for the last 12 months|Helius Medical Technologies Inc. - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Passage Bio, Inc.|NEUP (bionomics.com.au) - Net earnings per share for the last 12 months|Minerva (NERV) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months Athira Pharma, Inc.|ADXN: Earnings per share for the trailing year|Earnings per share for the last twelve months Alzamend Neuro, Inc. (ALZN)|CYCN - Net earnings per one share for the last twelve months|Earnings per share for the last twelve months Pasithea Therapeutics Corp. KTTA|CRGT (Cortigent Inc) - Earnings per one share for the last 12 months|ATXI - Earnings per share for the last twelve months|Earnings per share for the trailing year BCLI (brainstorm-cell.com)|Cara Therapeutics (CARA) - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months Chromocell Therapeutics Corp (CHRO)|Net earnings per share for the last 12 months ELYM|ITCI (Intra-Cellular) - Earnings per share for the last four quarters|Net earnings per share (EPS TTM) LBPH|Net earnings per share (EPS TTM) marinuspharma.com (MRNS)|Net earnings per share (EPS TTM) NKGN (NKGen Biotech)|Net earnings per share for the trailing year NeuroBo Pharmaceuticals Inc|Sage Therapeutics, Inc - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Synaptogenix, Inc|Trevena, Inc. (TRVN) - Earnings per share for the last twelve months|Earnings per share for the last 12 months VIGL|WENA (Anew Medical) - Net earnings per share (EPS TTM)|Cerevel Therapeutics Inc (CERE) - Net earnings per share for the last four quarters